Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions

Netherlands Heart Journal

Volumn 20, Issue 11, 2012, Pages 439-446

  Grundeken, M J ^a   Smits, M ^a   Harskamp, R E ^a   Damman, P ^a   Woudstra, P ^a   Hoorweg, A J ^a   Baan, J ^a   Arkenbout, E K ^a   Piek, J J ^a   Vis, M M ^a   Henriques, J P S ^a   Koch, K T ^a   Tijssen, J G ^a   de Winter, R J ^a   Wykrzykowska, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bifurcation lesions; Coronary artery disease; Dedicated bifurcation device; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY BIFURCATION LESION; CORONARY STENT; DEATH; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SEPSIS; STENT THROMBOSIS; THORAX PAIN;

EID: 84869819392     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-012-0302-x     Document Type: Article

References (28)

1. Sarno G, Lagerqvist B, Frobert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012; Jan 9.
2. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667-78.
3. Hildick-Smith D, Lassen JF, Albiero R, et al. Consensus from the 5th European Bifurcation Club meeting. EuroIntervention. 2010;6 (1):34-8.
4. Kaplan AV, Davis HR. Tryton side-branch stent. EuroIntervention. 2006;2(2):270-1.
5. Magro M, Wykrzykowska J, Serruys PW, et al. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis. Catheter Cardiovasc Interv. 2011;77(6):798-806.
6. Kaplan AV, Davis HR. Tryton side-branch stent. EuroIntervention. 2006;2(2):270-1.
7. Louvard Y, Medina A, Stankovic G. Definition and classification of bifurcation lesions and treatments. EuroIntervention. 2010;6 (Suppl J):J31-5.
8. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-53.
9. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-51.
10. Al SJ, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes Jr DR. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol. 2001;87(10):1139-44.
11. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drugeluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119(25):3198-206.
12. Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimuseluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation. 2004;109(11):1366-70.
13. Rathore S, Terashima M, Katoh O, et al. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention. 2009;5 (3):349-54.
14. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53(16):1399-409.
15. Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004;148 (5):857-64.
16. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109(10):1244-9.
17. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114 (18):1955-61.
18. Ferenc M, Gick M, Kienzle Rp, et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J. 2008;29(23):2859-67.
19. Colombo A, Bramucci E, Sacca S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: application of the crushing technique using Sirolimus-Eluting Stents) study. Circulation. 2009;119(1):71-8.
20. Hildick-Smith D, de Belder AJ, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation. 2010;121(10):1235-43.
21. Damman P, Wallentin L, Fox KA, et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 Trials (FIR). Circulation. 2011; Dec 23.
22. Bonaca MP, Wiviott SD, Braunwald E, et al. ACC/AHA/ESC/ WHF Universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial. Circulation. 2011; Dec 23.
23. Brar SS, GrayWA, Dangas G, et al. Bifurcation stenting with drugeluting stents: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2009;5(4):475-84.
24. Onuma Y, Muller R, Ramcharitar S, et al. Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. EuroIntervention. 2008;3(5):546-52.
25. Beijk MA, Rittersma SZ, Koch KT, et al. Percutaneous treatment of bifurcated lesions: a simple approach with a single bare metal R stent provides favourable long term clinical results. EuroIntervention. 2006;1(4):409-16.
26. Beijk MA, Klomp M, Koch KT, et al. One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent. Atherosclerosis. 2010;213(2):525-31.
27. Grundeken MJ, Stella PR, Wykrzykowska JJ. Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices. EuroIntervention. 2012;7(11):1249-53.
28. Stella PR, Belkacemi A, Dubois C, et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv. 2012; Mar 15.